XML 44 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]
In calculating the fair value of the warrants using the Black-Scholes model, the following assumptions were utilized:
 
Expected life (in years)
 
2
 
Volatility
 
68
%
Risk-free interest rate
 
1.23
%
Expected dividend rate
 
-
 
Schedule of Share-based Compensation, Activity [Table Text Block]
A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
 
 
 
2017
 
2016
 
 
 
Number of 
Options
 
Weighted Average
Grant Date Fair
Value
 
Number of 
Options
 
Weighted 
Average Grant 
Date Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-vested stock options at January 1
 
 
335,283
 
$
5.09
 
 
466,009
 
$
5.79
 
Granted
 
 
127,000
 
$
3.69
 
 
171,900
 
$
4.22
 
Vested
 
 
(207,457)
 
$
5.16
 
 
(290,141)
 
$
5.67
 
Exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Forfeited/Expired/Exchanged
 
 
(15,955)
 
$
5.15
 
 
(12,485)
 
$
6.17
 
Non-vested stock options at December 31
 
 
238,871
 
$
4.27
 
 
335,283
 
$
5.09
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
 
Expected life
 
6.25 years
 
Weighted average volatility
 
69
%
Forfeiture rate
 
14
%
Weighted average risk-free interest rate
 
1.94
%
Expected dividend rate
 
0
%
Schedule Of Employee Service Share Based Compensation Unrecognized Period Costs [Table Text Block]
At December 31, 2017, there was $436,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Plan. That cost is expected to be recognized in future years as follows:
 
2018
 
$
211,000
 
2019
 
 
144,000
 
2020
 
 
69,000
 
2021
 
 
12,000
 
 
 
$
436,000
 
Schedule Of Recognized Compensation Cost [Table Text Block]
The recognized compensation cost associated with the Plan is as follows:
 
 
 
2017
 
2016
 
Research and development
 
$
119,000
 
$
112,000
 
General and administrative
 
 
250,000
 
 
513,000
 
Effect on net loss
 
$
369,000
 
$
625,000
 
Effect on net loss per share
 
$
0.02
 
$
0.05
 
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]
The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31, 2017:
 
 
 
Total Outstanding Warrants
 
Exercise Price
 
Warrants
 
Wtd. Avg.
Exercise Price
 
Remaining Life
(in years)
 
$1.80
 
 
80,000
 
$
1.80
 
 
3.13
 
$4.00
 
 
2,395,471
 
$
4.00
 
 
1.07
 
$10.00
 
 
20,313
 
$
10.00
 
 
1.18
 
 
 
 
2,495,784
 
$
3.98
 
 
 
 
Equity Incentive Plan [Member]  
Schedule of Share-based Compensation, Activity [Table Text Block]
Activity under the Plan is as follows:
 
 
 
2017
 
2016
 
Reserved but unissued shares under the Plan, beginning of year
 
 
266,884
 
 
455,372
 
Increases in the number of authorized shares under the Plan
 
 
255,261
 
 
15,039
 
Grants of stock options
 
 
(127,000)
 
 
(171,900)
 
Stock option forfeitures
 
 
15,955
 
 
12,485
 
Exercise of stock options
 
 
-
 
 
-
 
Stock grants
 
 
(219,444)
 
 
(44,112)
 
Reserved but unissued shares under the Plan, end of year
 
 
191,656
 
 
266,884
 
Consultant Plan [Member]  
Schedule of Share-based Compensation, Activity [Table Text Block]
Activity under the Consultant Plan is as follows:
 
 
 
2017
 
2016
 
Reserved but unissued shares under the Consultant Plan at January 1
 
 
83,633
 
 
92,130
 
Increases in the number of authorized shares under the Consultant Plan
 
 
25,526
 
 
1,503
 
Stock grants
 
 
(10,000)
 
 
(10,000)
 
Reserved but unissued shares under the Consultant Plan at Period End
 
 
99,159
 
 
83,633
 
Warrant [Member]  
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]
A summary of the Company’s warrant activity and related information is as follows:
 
 
 
2017
 
2016
 
 
 
Warrants
 
Average
Exercise
Price
 
Warrants
 
Average 
Exercise
Price
 
Outstanding at January 1
 
 
445,313
 
$
4.65
 
 
564,272
 
$
4.14
 
Granted
 
 
2,395,471
 
$
4.00
 
 
-
 
 
-
 
Exercised
 
 
-
 
 
-
 
 
(118,959)
 
$
2.20
 
Forfeited/Expired
 
 
(345,000)
 
$
5.00
 
 
-
 
 
-
 
Outstanding at Period End
 
 
2,495,784
 
$
3.98
 
 
445,313
 
$
4.65
 
Employee Stock Option [Member]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s stock option activity and related information is as follows:
 
 
 
2017
 
2016
 
 
 
Options to
Purchase 
Common 
Stock
 
Weighted 
Average 
Exercise Price
 
Weighted Average
Remaining
Contractual Life (in
years)
 
Options to 
Purchase 
Common
Stock
 
Weighted 
Average 
Exercise Price
 
Weighted
Average
Remaining
Contractual
Life (in years)
 
Outstanding at January 1
 
 
882,815
 
$
4.98
 
 
7.51
 
 
723,400
 
$
5.18
 
 
8.10
 
Granted
 
 
127,000
 
$
3.69
 
 
9.48
 
 
171,900
 
$
4.22
 
 
9.26
 
Exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
 
-
 
 
-
 
Forfeited/Expired/Exchanged
 
 
(15,955)
 
$
5.15
 
 
-
 
 
(12,485)
 
$
6.17
 
 
-
 
Outstanding at December 31
 
 
993,860
 
$
4.81
 
 
6.94
 
 
882,815
 
$
4.98
 
 
7.51
 
Exercisable at December 31
 
 
754,989
 
$
4.98
 
 
6.32
 
 
547,532
 
$
4.91
 
 
6.85